| Product Code: ETC8284898 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Oncology NGS Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Oncology NGS Market - Industry Life Cycle |
3.4 Mexico Oncology NGS Market - Porter's Five Forces |
3.5 Mexico Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Mexico Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Mexico Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Mexico Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Mexico Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Mexico Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Mexico |
4.2.2 Technological advancements in Next-Generation Sequencing (NGS) for oncology |
4.2.3 Growing investments in healthcare infrastructure and research in Mexico |
4.3 Market Restraints |
4.3.1 High cost associated with NGS technologies |
4.3.2 Limited reimbursement policies for NGS-based oncology tests in Mexico |
4.3.3 Lack of skilled professionals and expertise in NGS data analysis |
5 Mexico Oncology NGS Market Trends |
6 Mexico Oncology NGS Market, By Types |
6.1 Mexico Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Mexico Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Mexico Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Mexico Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Mexico Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Mexico Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Mexico Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Mexico Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Mexico Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Mexico Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Mexico Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Mexico Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Mexico Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Mexico Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Mexico Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Mexico Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Mexico Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Mexico Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Mexico Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Mexico Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Mexico Oncology NGS Market Import-Export Trade Statistics |
7.1 Mexico Oncology NGS Market Export to Major Countries |
7.2 Mexico Oncology NGS Market Imports from Major Countries |
8 Mexico Oncology NGS Market Key Performance Indicators |
8.1 Adoption rate of NGS technologies in oncology diagnostics |
8.2 Number of research collaborations between industry players and academic institutions in Mexico |
8.3 Rate of development and approval of NGS-based oncology tests in the market |
9 Mexico Oncology NGS Market - Opportunity Assessment |
9.1 Mexico Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Mexico Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Mexico Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Mexico Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Mexico Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Mexico Oncology NGS Market - Competitive Landscape |
10.1 Mexico Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Mexico Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here